Immunome Inc (IMNM)
11.22
-0.05
(-0.44%)
USD |
NASDAQ |
Jan 06, 16:00
11.16
-0.06
(-0.53%)
After-Hours: 20:00
Immunome Total Liabilities (Quarterly): 41.99M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 10.68M |
| IGC Pharma Inc | 2.992M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Protalix BioTherapeutics Inc | 29.13M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 256.90M |
| Shareholders Equity (Quarterly) | 214.91M |
| Current Ratio | 6.174 |